Looking at the Future of Hospital Safety and Treatment Resistance

Video

The search for newer antimicrobial agents is a focus of those looking to help prevent patients from developing potentially dangerous conditions while admitted to the hospital.

The search for newer antimicrobial agents is a focus of those looking to help prevent patients from developing potentially dangerous conditions while admitted to the hospital.

As of now the US Food and Drug Administration has approved two such agents, but Thomas M. File, Jr., from Summa Health System said he hopes to see that number grow in the near future in order to better treat more potential at risk patients. File said they are also working to ensure that the organisms will not cause as much damage to the host systems makgin them less of an overall health threat to the patients.

Related Videos
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
A Promising Pipeline for COPD
Projecting Dupilumab's Fit in COPD
What the Ensifentrine FDA Approval Means for COPD
Ralph DeFronzo, MD | Credit: UT San Antonio
Signs and Symptoms of Connective Tissue Disease
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Edward V Loftus, Jr, MD | Credit: Mayo Clinic
© 2024 MJH Life Sciences

All rights reserved.